Dr. Raymond Tjandrawinata, executive director at Dexa Laboratories of Biomolecular Sciences (DLBS), talks about collective conscience, co-evolving with pathogens, and the first monoclonal antibody therapy in Indonesia—a breakthrough treatment for patients with preexisting comorbidities and elderlies.
In collaboration with PT Dexa Medica.
